Pages that link to "Item:Q2792760"
From MaRDI portal
The following pages link to Methodological approach to determine minor, considerable, and major treatment effects in the early benefit assessment of new drugs (Q2792760):
Displaying 3 items.
- A Bayesian approach to probabilistic sensitivity analysis in structured benefit-risk assessment (Q2792759) (← links)
- A framework to assess the value of application of formal criteria to check clinical relevance in RCTs as part of a benefit assessment strategy (Q2792762) (← links)
- Effect size measures and their benchmark values for quantifying benefit or risk of medicinal products (Q5208172) (← links)